Venus Concept Expands Executive Team
2020年3月3日 - 9:05PM
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ:
VERO), a global medical aesthetic technology leader, announced that
it has expanded its Executive Team with the appointment of Chad A.
Zaring to the newly-created role of Chief Commercial Officer
(“CCO”), effective February 10, 2020. Mr. Zaring has extensive
experience in building and executing commercial strategies and
driving sales for leading surgical robotics companies in his
career.
“We are very excited to have Chad join our
executive leadership team in a newly created role of Chief
Commercial Officer,” said Dom Serafino, Chief Executive Officer of
Venus Concept Inc. “Chad is an industry veteran with the requisite
experience leading global commercial strategies for innovative
medical device companies which makes him an ideal fit. As CCO, he
is responsible for global sales of both devices and services, as
well as leading the development of Venus Concept’s commercial
strategy to introduce new, minimally invasive, robotic solutions
for medical aesthetic procedures that are only treated with
invasive surgical interventions today.”
“This role represents a great opportunity given
Venus Concept’s strong product portfolio, disruptive business
model, and unique approach to creating lasting customer
relationships, combined with their focus on robotics and innovative
technology. I’m eager to leverage these strengths to drive our
commercial success,” said Mr. Zaring.
Prior to joining the Venus Concept, Mr. Zaring
served as the Chief Commercial Officer at Titan Medical Inc., a
publicly traded medical device company focused on the design,
development and commercialization of a robotic surgical system for
application in minimally invasive surgery.
Prior to Titan Medical, Mr. Zaring was Vice President of
Robotics, Imaging and Navigation at Medtronic. Prior to Medtronic,
he was part of the Senior Leadership Team at Mazor Robotics
responsible for the initiation of a Global Distribution Agreement
which subsequently led to the acquisition by Medtronic. In his
sales leadership roles at both companies, he developed capital
sales strategies, established new sales channels and consistently
exceeded sales goals.
Earlier in his career, from October 2004 to April 2015, Mr.
Zaring held positions of increasing responsibility at Intuitive
Surgical and was a member of the leadership team that executed
early and mid-stage adoption of their robotic surgery system across
multiple surgical disciplines. Mr. Zaring began his career at
Merrill Lynch in 1999 as a financial sales consultant. He later
held sales positions at Merck and Co. and at Ethicon Endo-Surgery,
a Johnson & Johnson company. He holds a Bachelor of Arts
degree in biology from Juniata College, Huntingdon, PA.
About Venus Concept
Venus Concept is an innovative global medical aesthetic
technology leader with a broad product portfolio of minimally
invasive and non-invasive medical aesthetic technologies and reach
in over 60 countries and 29 direct markets. Venus
Concept focuses its product sales strategy on a
subscription-based business model in North America and in
its well-established direct global markets. Venus Concept’s product
portfolio consists of aesthetic device platforms,
including Venus Versa, Venus Legacy, Venus
Velocity, Venus Fiore, Venus Viva, Venus Freeze Plus, and
Venus Bliss. Venus Concept’s hair restoration division includes
NeoGraft, an automated hair restoration system that facilitates the
harvesting of follicles during a FUE process and the
ARTAS® and ARTAS iX™ Robotic Hair Restoration Systems,
which harvest follicular units directly from the scalp and create
recipient implant sites using proprietary algorithms. Venus
Concept has been backed by leading healthcare industry growth
equity investors including EW Healthcare
Partners (formerly Essex Woodlands), HealthQuest
Capital, Longitude Capital Management, and Aperture
Venture Partners.
Investor Relations Contact:
Westwicke Partners on behalf of Venus Concept
Mike Piccinino, CFA
VenusConceptIR@westwicke.com
Restoration Robotics (NASDAQ:HAIR)
過去 株価チャート
から 5 2024 まで 6 2024
Restoration Robotics (NASDAQ:HAIR)
過去 株価チャート
から 6 2023 まで 6 2024